Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1986 Sep;407(3):299-304.
doi: 10.1007/BF00585306.

The effect of acetylstrophanthidin on the responsiveness of left atrial type B receptors to saline infusion and veratrine injection in anaesthetized cats

The effect of acetylstrophanthidin on the responsiveness of left atrial type B receptors to saline infusion and veratrine injection in anaesthetized cats

M Fahim et al. Pflugers Arch. 1986 Sep.

Abstract

In order to investigate whether the cardiac glycoside, acetylstrophanthidin, influenced the sensitivity of atrial receptors to saline infusion and veratrine injection, experiments were performed on anaesthetized, artificially ventilated and thoracotomised cats. The following was found: Intravenous injection of acetylstrophanthidin did not change the basal activity or the stimulus-response relationship of left atrial type B receptors. Before acetylstrophanthidin, administration of small doses of veratrine (10-20 micrograms/kg) produced either a mild stimulation or no stimulation of these receptors. After acetylstrophanthidin, injections of veratrine (10-20 micrograms/kg) produced a marked/sustained stimulation of all the type B receptors investigated; in the case of a few units, even subthreshold doses of veratrine produced significant stimulation. The data indicate that acetylstrophanthidin does not sensitize the type B atrial receptors to their natural stimulus; however, it increases their sensitivity to drugs probably by enhancing the drug-induced depolarisation caused by blocking the sodium pump.

PubMed Disclaimer

Similar articles

References

    1. Pharmacol Rev. 1977 Sep;29(3):187-220 - PubMed
    1. J Exp Biol. 1983 Nov;107:491-3 - PubMed
    1. J Physiol. 1953 Dec 29;122(3):610-36 - PubMed
    1. Neuropharmacology. 1970 Jul;9(4):399-402 - PubMed
    1. J Physiol. 1963 Nov;169:116-36 - PubMed

LinkOut - more resources